Ensysce Biosciences, Inc. (ENSC) vs Exicure, Inc. (XCUR)
A side-by-side comparison of Ensysce Biosciences, Inc. and Exicure, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENSC
Ensysce Biosciences, Inc.
$0.43HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
XCUR
Exicure, Inc.
$1.10HealthcareDelayed quote: Oct 6, 2026, 2:52 PM EDT
Total return — ENSC vs XCUR
growth of $100 · dividends reinvested · last 8yENSC -100.0% (-75.7%/yr)XCUR -99.8% (-53.2%/yr)XCUR compounded faster over this window
Log scale — wide-divergence pair
ENSC XCUR
ENSC vs XCUR: by the numbers
- •XCUR is the larger company ($7M vs $7M market cap).
- •Both run net losses; XCUR's is the smaller (0.00% vs -1084.23% net margin).
Metrics side by side
Valuation
| Metric | ENSC | XCUR |
|---|---|---|
| P/S ratio | 5.67 | N/A |
| P/B ratio | N/A | 7.18 |
Profitability
| Metric | ENSC | XCUR |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -1084.23% | 0.00% |
| ROE | N/A | -847.90% |
| ROIC | N/A | -101.07% |
Growth (annualized)
| Metric | ENSC | XCUR |
|---|---|---|
| Total return CAGR (5Y) | -86.22% | -64.13% |
Frequently asked
- How have ENSC and XCUR total returns compared?
- Over the past 5 years, ENSC delivered -86.22% and XCUR delivered -64.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.